Aperio Group’s Genomic Health, Inc. GHDX Stock Holding History

Aperio Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,324	Closed	-$293K	–	2377
2019 Q3	$293K	Buy	4,324 +625	+17%	+$42.9K	﹤0.01%	2030
2019 Q2	$215K	Sell	3,699 -1,577	-30%	-$93.4K	﹤0.01%	2155
2019 Q1	$370K	Buy	5,276 +548	+12%	+$40.6K	﹤0.01%	1906
2018 Q4	$305K	Buy	4,728 +1,352	+40%	+$94.8K	﹤0.01%	1938
2018 Q3	$237K	Buy	+3,376	New	+$197K	﹤0.01%	2121

Aperio Group's GHDX Position: Q4 2019 in Review

Aperio Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,324 shares — an estimated $293K sold.

Aperio Group first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $370K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Aperio Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Aperio Group sold 4,324 Genomic Health, Inc. shares in Q4 2019, an estimated $293K.
Aperio Group first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Aperio Group's Genomic Health, Inc. position peaked at $370K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.